Current status and prospects of laboratory tests for inflammatory bowel disease.
10.3760/cma.j.cn112150-20230112-00025
- Author:
Yue Ying LI
1
;
Wei Wei LIU
2
Author Information
1. Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China Department of Central Laboratory, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200070, China.
2. Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Inflammatory Bowel Diseases/pathology*;
Colonoscopy;
Diet;
Feces
- From:
Chinese Journal of Preventive Medicine
2023;57(10):1687-1692
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the gastrointestinal tract, with a global incidence increasing year by year, and the incidence of IBD in developing countries has been increasing since the end of the last century. The pathogenesis of IBD remains unclear, which is the combined result of genetic, immune, diet, environmental and other factors. There is no gold standard for the diagnosis of IBD. Colonoscopy and mucosal biopsy are the preferred clinical tests, but these invasive and time-consuming methods are not conducive to early screening and frequent monitoring. Therefore, convenient, fast, non-invasive and reliable methods are urgently needed to assist the clinical diagnosis and evaluation of IBD. This paper aims to elaborate the laboratory diagnosis and monitoring methods of IBD based on fecal and blood indicators, which can provide ideas for the prevention, screening, diagnosis and monitoring of IBD, and help reduce its burden on people's living standards, public health and society.
